\-\ Texto\\:\\ \ \(0\)\
\-\ none\ \(204\)\
\-\ 1\\.\\ axial\\ ct\\ images\\ that\\ were\\ obtained\\ in\\ the\\ normal\\ abdominal\\ protocol\\.\\ \\ the\\ images\\ are\\ in\\ arterial\\ phase\\ as\\ seen\\ by\\ the\\ contrast\\ filled\\ aorta\\.\\ \\ the\\ liver\\ is\\ abnormally\\ heterogenous\\ in\\ attenuation\\.\\ \\ the\\ next\\ image\\ shows\\ the\\ abnormal\\ increase\\ attenuation\\ of\\ the\\ hepatic\\ veins\\.\\ \\ the\\ next\\ image\\ shows\\ enlarge\\ portal\\ vein\\ and\\ as\\ the\\ vein\\ reaches\\ the\\ periphery\\,\\ there\\ is\\ pooling\\ of\\ the\\ contrast\\.\\ \\ the\\ last\\ image\\ shows\\ a\\ large\\ common\\ hepatic\\ artery\\.\\ \\ these\\ findings\\ are\\ consistent\\ with\\ arterial\\ venous\\ shunting\\ which\\ may\\ be\\ caused\\ by\\ hereditary\\ hemorrhagic\\ telangiectasia\\ or\\ a\\ diffuse\\ neoplastic\\ process\\.\\ \\ the\\ patient\\ has\\ a\\ history\\ of\\ \\ hereditary\\ hemorrhagic\\ telangiectasia\\ and\\ cutaneous\\ lesions\\.\ \(0\)\
\-\ hereditary\\ hemorrhagic\\ telangiectasia\\ \\(hht\\)\\ and\\ pulmonary\\ arteriovenous\\ malformation\\ \\(avm\\)\ \(0\)\
\-\ 1\\.\\ arterial\\ venous\\ malformation\ \(1\)\
\-\ 2\\.\\ diffuse\\ hepatic\\ cellular\\ carcinoma\\ or\\ diffuse\\ metastatic\\ disease\ \(1\)\
\-\ rule\\ out\\ diverticular\\ disease\\ in\\ patient\\ with\\ abdominal\\ pain\ \(0\)\
\-\ see\\ factoid\\.\ \(59\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ telangiectasia\\:\\ 0\\.3308518550455389\ \(0\)\
\-\ hereditary\\:\\ 0\\.2904498696476354\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.24506833444712428\ \(0\)\
\-\ the\\:\\ 0\\.24428510045449506\ \(0\)\
\-\ arterial\\:\\ 0\\.232663723164098\ \(0\)\
\-\ hepatic\\:\\ 0\\.22498668521058376\ \(0\)\
\-\ image\\:\\ 0\\.18068355058353053\ \(0\)\
\-\ diffuse\\:\\ 0\\.17717660489404274\ \(0\)\
\-\ next\\:\\ 0\\.17588945786746568\ \(0\)\
\-\ shows\\:\\ 0\\.165816292626921\ \(0\)\
\-\ malformation\\:\\ 0\\.14526617774271047\ \(0\)\
\-\ attenuation\\:\\ 0\\.14411258289009116\ \(0\)\
\-\ vein\\:\\ 0\\.13500583052437748\ \(0\)\
\-\ venous\\:\\ 0\\.134472405448963\ \(0\)\
\-\ hht\\:\\ 0\\.132467866163093\ \(0\)\
\-\ diverticular\\:\\ 0\\.12771848053566476\ \(0\)\
\-\ reaches\\:\\ 0\\.11970316062842865\ \(0\)\
\-\ pooling\\:\\ 0\\.11847970122122581\ \(0\)\
\-\ enlarge\\:\\ 0\\.11734068776292261\ \(0\)\
\-\ cellular\\:\\ 0\\.10890739244159905\ \(0\)\
\-\ shunting\\:\\ 0\\.10589741905664753\ \(0\)\
\-\ abdominal\\:\\ 0\\.10301271591180038\ \(0\)\
\-\ cutaneous\\:\\ 0\\.09779765320051179\ \(0\)\
\-\ periphery\\:\\ 0\\.09501383605099248\ \(0\)\
\-\ in\\:\\ 0\\.09370992003941749\ \(0\)\
\-\ abnormally\\:\\ 0\\.09364866635725708\ \(0\)\
\-\ protocol\\:\\ 0\\.09190925411478033\ \(0\)\
\-\ contrast\\:\\ 0\\.09151462396240968\ \(0\)\
\-\ arteriovenous\\:\\ 0\\.09033576434445015\ \(0\)\
\-\ portal\\:\\ 0\\.09012274013703167\ \(0\)\
\-\ heterogenous\\:\\ 0\\.08870390392870228\ \(0\)\
\-\ images\\:\\ 0\\.0871236574502158\ \(0\)\
\-\ neoplastic\\:\\ 0\\.08704236516558775\ \(0\)\
\-\ veins\\:\\ 0\\.08357056734471739\ \(0\)\
\-\ avm\\:\\ 0\\.08328835283126593\ \(0\)\
\-\ phase\\:\\ 0\\.0805843310551767\ \(0\)\
\-\ by\\:\\ 0\\.07998363861818443\ \(0\)\
\-\ disease\\:\\ 0\\.07906195163430323\ \(0\)\
\-\ last\\:\\ 0\\.0765944697524191\ \(0\)\
\-\ aorta\\:\\ 0\\.07650146022745775\ \(0\)\
\-\ filled\\:\\ 0\\.0757756665596994\ \(0\)\
\-\ as\\:\\ 0\\.07566622194718665\ \(0\)\
\-\ increase\\:\\ 0\\.07559909645931268\ \(0\)\
\-\ caused\\:\\ 0\\.07551151457213517\ \(0\)\
\-\ rule\\:\\ 0\\.07474350879492037\ \(0\)\
\-\ are\\:\\ 0\\.07146963770249022\ \(0\)\
\-\ process\\:\\ 0\\.0706316211740511\ \(0\)\
\-\ obtained\\:\\ 0\\.06661314210145221\ \(0\)\
\-\ factoid\\:\\ 0\\.06576888146804565\ \(0\)\
\-\ or\\:\\ 0\\.06552304166354611\ \(0\)\
\-\ liver\\:\\ 0\\.06496570306071911\ \(0\)\
\-\ out\\:\\ 0\\.0619020163915281\ \(0\)\
\-\ patient\\:\\ 0\\.0612602671620689\ \(0\)\
\-\ see\\:\\ 0\\.05858215143175414\ \(0\)\
\-\ artery\\:\\ 0\\.05848843795203343\ \(0\)\
\-\ and\\:\\ 0\\.05837982489098725\ \(0\)\
\-\ pulmonary\\:\\ 0\\.05740350515471142\ \(0\)\
\-\ abnormal\\:\\ 0\\.05657858720171317\ \(0\)\
\-\ carcinoma\\:\\ 0\\.056330738805067906\ \(0\)\
\-\ of\\:\\ 0\\.0552884114362586\ \(0\)\
\-\ axial\\:\\ 0\\.05439839383635789\ \(0\)\
\-\ lesions\\:\\ 0\\.05408530070183511\ \(0\)\
\-\ common\\:\\ 0\\.05340754769029332\ \(0\)\
\-\ these\\:\\ 0\\.05318014537570179\ \(0\)\
\-\ metastatic\\:\\ 0\\.05164982754794855\ \(0\)\
\-\ is\\:\\ 0\\.0515804788307779\ \(0\)\
\-\ none\\:\\ 0\\.05146559460922951\ \(0\)\
\-\ consistent\\:\\ 0\\.051063403049832805\ \(0\)\
\-\ were\\:\\ 0\\.04854406936956326\ \(0\)\
\-\ may\\:\\ 0\\.04739141762298829\ \(0\)\
\-\ large\\:\\ 0\\.04718593970844782\ \(0\)\
\-\ findings\\:\\ 0\\.046478735901915355\ \(0\)\
\-\ seen\\:\\ 0\\.04433644212579059\ \(0\)\
\-\ has\\:\\ 0\\.04301602208962989\ \(0\)\
\-\ which\\:\\ 0\\.04282193730308765\ \(0\)\
\-\ that\\:\\ 0\\.04086806307920729\ \(0\)\
\-\ normal\\:\\ 0\\.038450686830122295\ \(0\)\
\-\ be\\:\\ 0\\.03820270054323241\ \(0\)\
\-\ there\\:\\ 0\\.03747161453978753\ \(0\)\
\-\ with\\:\\ 0\\.03688096416594484\ \(0\)\
\-\ history\\:\\ 0\\.03597998913297447\ \(0\)\
\-\ ct\\:\\ 0\\.035852995068198494\ \(0\)\
\-\ pain\\:\\ 0\\.033698987863236156\ \(0\)\
